Pacira BioSciences, Inc. Board of Directors

Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature to targeted nerves. It has a development and commercialization, and supply agreement with Aratana Therapeutics, Inc. for NOCITA, a bupivacaine liposome injectable suspension product. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.

Mr. Shawn M. Cross

Mr. Shawn M. Cross

Chief Financial Officer

Mr. Daryl Gaugler

Mr. Daryl Gaugler

Chief Operating Officer

Ms. Kristen Williams J.D.

Ms. Kristen Williams J.D.

Chief Administrative Officer & Secretary

Mr. Anthony Molloy III, Esq.

Mr. Anthony Molloy III, Esq.

Chief Legal & Compliance Officer

Ms. Lauren Bullaro Riker

Ms. Lauren Bullaro Riker

Principal Accounting Officer & Senior VP of Finance

Ms. Susan Mesco

Ms. Susan Mesco

Head of Investor Relations

Leaving Board of Directors Review Your about to visit the following url Invalid URL

Loading...
Comments


Comment created.